Viewing Study NCT04646395


Ignite Creation Date: 2025-12-24 @ 1:39 PM
Ignite Modification Date: 2025-12-27 @ 10:13 PM
Study NCT ID: NCT04646395
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-01-30
First Post: 2020-11-17
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Study of Acalabrutinib and Tafasitamab in MZL Patients
Sponsor: International Extranodal Lymphoma Study Group (IELSG)
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module